HuGE Literature Finder
Records 1-5
|
The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.
Radiology and oncology 2019 Mar . Levpuscek Kristina, Goricar Katja, Kovac Viljem, Dolzan Vita, Franko Alen |
|
Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.
Scientific reports 2017 Apr 7 46537. Gori?ar Katja, Kova? Viljem, Dolžan Vi |
|
Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
Clinical lung cancer 2014 Nov 15 (6): 455-65. Powrózek Tomasz, Kowalski Dariusz M, Krawczyk Pawe?, Ramlau Rodryg, Kucharczyk Tomasz, Kalinka-Warzocha Ewa, Knetki-Wróblewska Magdalena, Winiarczyk Kinga, Dyszkiewicz Wojciech, Krzakowski Maciej, Milanowski Janu |
|
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Apr 23 (4): 961-7. Er?ulj N, Kova? V, Hmeljak J, Dolžan |
|
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
Mutation research 2011 Mar 708 (1-2): 11-20. Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, Mirabelli D, Casadio C, Ardissone F, Ruffini E, Betta P G, Libener R, Guaschino R, Matullo G, Piccolini E, Magnani C, Dianzani |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: